Opiant Pharmaceuticals, Inc. announced that the Dr. Michael Sinclair will transition from the role of Executive Chairman of the company to the company’s Chairman of the Board of Directors (the “Board”), a position which he currently holds. Pursuant to Section 3.6 of the company’s Bylaws, Dr. Sinclair was appointed by the Board and shall serve in such capacity until his successor is duly appointed and qualified. The Board shall appoint the Chairman of the Board on an annual basis.